A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia

Fanny W S Ko, Margaret Ip, Paul K S Chan, Susanna S S Ng, S S Chau, David S C Hui, Fanny W S Ko, Margaret Ip, Paul K S Chan, Susanna S S Ng, S S Chau, David S C Hui

Abstract

Aim: This study assessed the infectious etiology of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) with concomitant pneumonia.

Methods: Patients admitted to medical wards in an acute hospital were recruited prospectively from May 1, 2004 to April 30, 2005. Sputum culture, blood culture, paired serology, and nasopharyngeal aspirates (NPA) viral culture and polymerase chain reaction (PCR) studies were performed. Spirometry was assessed in stable phase at 2-3 months post-hospital discharge.

Results: Seventy eight subjects were admitted for AECOPD with concomitant pneumonia. The mean (SD) age was 77.1 (7.5) years, with FEV(1) of 41.5 (20.8)% predicted normal. Overall, an infectious etiology could be established in 48.7% of the subjects. Among the 71 subjects with sputum collected, 40.8% had positive bacterial culture. The commonest bacteria identified were Streptococcus pneumoniae (8[11.3%]), Pseudomonas aeruginosa (7[9.9%]) and Haemophilus influenzae (7[9.9%]). Among the 66 subjects with NPA collected, 9.0 and 12.2% had positive viral culture and PCR results, respectively. The commonest viruses identified by NPA PCR were influenza A (4[6.1%] subjects) and rhinovirus (2[3.0%]). Paired serology was positive in 4.4%. Patients on high dose inhaled corticosteroid (ICS) (>1000 mcg beclomethasone-equivalent/day) had a higher rate of positive sputum bacterial culture than those on low-medium dose of ICS (50.0% vs 18.2%, p=0.02).

Conclusion: An infectious etiology could be established in about half of patients hospitalized with AECOPD and concomitant pneumonia. The majority of identifiable causes were bacterial. Patients on high dose ICS might have impaired airway defense as reflected by the higher rate of positive sputum culture.

References

    1. Bodi M., Rodriguez A., Sole-Violan J., Gilavert M.C., Garnacho J., Blanquer J. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis. 2005;41(12):1709–1716.
    1. Center of Health Protection. The Government of the Hong Kong Special Administrative Region. Monthly summary tables of influenza virus isolation 2006. <.
    1. Restrepo M.I., Mortensen E.M., Pugh J.A., Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28(2):346–351.
    1. Ernst P., Gonzalez A.V., Brassard P., Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med. 2007;176(2):162–166.
    1. Marrie T.J., Durant H., Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis. 1989;11(4):586–599.
    1. Pachon J., Prados M.D., Capote F., Cuello J.A., Garnacho J., Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis. 1990;142(2):369–373.
    1. Liam C.K., Lim K.H., Wong C.M. Community-acquired pneumonia in patients requiring hospitalization. Respirology. 2001;6(3):259–264.
    1. Brozek J., McDonald E., Clarke F., Gosse C., Jaeschke R., Cook D. Pneumonia observational incidence and treatment: a multidisciplinary process improvement study. Am J Crit Care. 2007;16(3):214–219.
    1. Nag V.L., Ayyagari A., Venkatesh V., Dash N.R., Ghar M., Prasad K.N. Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center. J Commun Dis. 2005;37(4):281–287.
    1. Ko F.W., Ip M., Chan P.K., Fok J.P., Chan M.C., Ngai J.C. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest. 2007;131(1):44–52.
    1. Ko F.W., Ip M., Chan P.K., Chan M.C., To K.W., Ng S.S. Viral etiology of acute exacerbations of chronic obstructive pulmonary disease in Hong Kong. Chest. 2007;132(3):900–908.
    1. Groenewegen K.H., Wouters E.F. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med. 2003;97(7):770–777.
    1. Rohde G., Wiethege A., Borg I., Kauth M., Bauer T.T., Gillissen A. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58(1):37–42.
    1. Ko F.W., Lam R.K., Li T.S., Fok J.P., Chan M.C., Ng T.K. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong. Intern Med J. 2005;35(11):661–667.
    1. Torres A., Dorca J., Zalacain R., Bello S., El-Ebiary M., Molinos L. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med. 1996;154(5):1456–1461.
    1. National Heart, Lung and Blood Institute . World Health Organization; 2006. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2006.
    1. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422.
    1. Patel I.S., Seemungal T.A., Wilks M., Lloyd-Owen S.J., Donaldson G.C., Wedzicha J.A. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57(9):759–764.
    1. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
    1. Standard unit, evaluations and standards laboratory. Standard operating procedure for the investigation of sputum. BSOP8. Health Protection Agency, Standard Operating Procedures Technical Services, PHLS HQ, UK 2003;(5.1):1–19.
    1. Lam W., Yeung A.C., Tang J.W., Ip M., Chan E.W., Hui M. Rapid multiplex nested-PCR for detection of respiratory viruses. J Clin Microbiol. 2007
    1. Standardization of Spirometry, 1994 Update Am J Respir Crit Care Med. 1995;152(3):1107–1136. American Thoracic Society.
    1. Ip M.S., Ko F.W., Lau A.C., Yu W.C., Tang K.S., Choo K. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129(2):384–392.
    1. Diederen B.M., van der Valk P.D., Kluytmans J.A., Peeters M.F., Hendrix R. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;30(2):240–244.
    1. Lieberman D., Gelfer Y., Varshavsky R., Dvoskin B., Leinonen M., Friedman M.G. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest. 2002;122(4):1264–1270.
    1. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789.
    1. Belvisi M.G. Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc. 2004;1(3):207–214.
    1. Diaz A., Barria P., Niederman M., Restrepo M.I., Dreyse J., Fuentes G. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest. 2007;131(3):779–787.
    1. Chan C.H., Cohen M., Pang J. A prospective study of community-acquired pneumonia in Hong Kong. Chest. 1992;101(2):442–446.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera